Clinical Trial Update: Phase 2 Trial of Therapeutic Hepatitis B Vaccine (Mimogen-based) for Chronic Hepatitis B [Phase 2]

View source ↗

Summary

Phase 2 trial of a Mimogen-based therapeutic hepatitis B vaccine for chronic hepatitis B has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Mimogen-based Therapeutic Hepatitis B Vaccine

Snippet

Sponsor: Chongqing Jiachen Biotechnology Ltd. | Conditions: Chronic Hepatitis B | Phase 2 | Status: COMPLETED | Results posted: 2017-01-18